VTX-003

N/A

Report date: 2024/12/26 17:39:22

Base Information

Drug NameVTX-003
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCatenin beta 1 inhibitorsWnt signalling pathway inhibitorsBCL9 Transcription Coactivator inhibitors
TargetsCatenin beta 1BCL9 Transcription Coactivator
Therapy Area/IndicationsOvarian NeoplasmsLiver NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVenn Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesVenn Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsLiver NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A